Intersect ENT
XENT
#6270
Rank
ยฃ0.72 B
Marketcap
ยฃ21.57
Share price
0.00%
Change (1 day)
17.45%
Change (1 year)

Revenue for Intersect ENT (XENT)

Revenue in 2021: ยฃ81.53 Million

According to Intersect ENT's latest financial reports the company's current revenue (TTM ) is ยฃ81.53 Million. In 2021 the company made a revenue of ยฃ81.53 Million an increase over the revenue in the year 2020 that were of ยฃ61.52 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intersect ENT from 2012 to 2021

Annual revenue

Year Revenue Change
2021ยฃ81.53 M32.52%
2020ยฃ61.52 M-26.19%
2019ยฃ83.36 M0.62%
2018ยฃ82.85 M12.64%
2017ยฃ73.55 M22.35%
2016ยฃ60.11 M27.79%
2015ยฃ47.04 M59.62%
2014ยฃ29.47 M115.2%
2013ยฃ13.69 M205.83%
2012ยฃ4.47 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ocular Therapeutix
OCUL
ยฃ39.76 M-51.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
ยฃ6.34 B 7,686.64%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Anika Therapeutics
ANIK
ยฃ92.15 M 13.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
ยฃ1.05 B 1,195.07%๐Ÿ‡บ๐Ÿ‡ธ USA